KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to $247.3 million.

  • BioNTech SE's Other Non-Current Liabilities fell 69.22% to $247.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.3 million, marking a year-over-year decrease of 69.22%. This contributed to the annual value of $93.5 million for FY2024, which is 563.38% up from last year.
  • As of Q3 2025, BioNTech SE's Other Non-Current Liabilities stood at $247.3 million, which was up 50.02% from $164.8 million recorded in Q2 2025.
  • BioNTech SE's 5-year Other Non-Current Liabilities high stood at $803.3 million for Q3 2024, and its period low was $6.8 million during Q1 2021.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $268.3 million (2024), whereas its average is $291.8 million.
  • In the last 5 years, BioNTech SE's Other Non-Current Liabilities skyrocketed by 23,341.93% in 2021 and then plummeted by 91.80% in 2022.
  • Quarterly analysis of 5 years shows BioNTech SE's Other Non-Current Liabilities stood at $211.5 million in 2021, then plummeted by 91.80% to $17.3 million in 2022, then fell by 18.73% to $14.1 million in 2023, then skyrocketed by 563.38% to $93.5 million in 2024, then tumbled by 69.22% to $247.3 million in 2025.
  • Its last three reported values are $247.3 million in Q3 2025, $164.8 million for Q2 2025, and $128.2 million during Q1 2025.